Mini review · 20 Dec 2021
Research articlePublished 2013
Internal Facilitation Committees Improving Protocol Design Feasibility
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Biopharmaceutical companies are actively seeking ways to simplify study design complexity and improve protocol feasibility. One new approach adopted by a growing number of companies has been to establish internal facilitation committees charged with evaluating the benefits and costs of various study design elements (e.g. volunteer eligibility criteria and protocol procedures). In late 2012, Tufts CSDD conducted in-depth interviews and compiled and analyzed profiles of internal facilitation committees implemented recently by ten major pharmaceutical. This article discusses common committee characteristics and goals and highlights implementation challenges and early measures of committee impact.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 2014
An Experience Feedback Committee for Improving Medication Process Safety: An Observational Study in a Hospital Pharmacy Department
Short communication · 28 Nov 2025
Protocol Development and Feasibility Testing in a Pilot Clinical Trial
Research article · 12 Feb 2021
Feasibility of Establishing a Return-to-Work Protocol Based on COVID-19 Antibodies Testing
Other · 2017
Nivolumab Maintenance as Monotherapy after Carboplatin Plus Nab- Paclitaxel for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer: Study Protocol for Feasibility
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 13 Feb 2026
Regulatory Scenario of Pharmaceuticals during COVID-19 Pandemic in India
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Kenneth A Getz”
- BylineArticles whose byline prints “Jennifer Kim”

